Parents’ attitude toward multiple vaccinations at a single visit with alternative delivery methods-Reference-Cited by-同舟云学术

Parents’ attitude toward multiple vaccinations at a single visit with alternative delivery methods

Published:2014-06-23 Issue:8 Volume:10 Page:2483-2489
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Kaaijk Patricia,Kleijne Deborah E,Knol Mirjam J,Harmsen Irene A,Ophorst Olga JAE,Rots Nynke Y

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/hv.29361

Reference24 articles.

1. Plotkin SL, Plotkin SA. A short history of vaccination: 1-16. In: Plotkin S, Orenstein W, Offit PA. Vaccines, 5th edition, Philadelphia: Saunders (Elsevier Inc.), 2008.

2. Towards tailored vaccine delivery: Needs, challenges and perspectives

3. Frontiers of transcutaneous vaccination systems: Novel technologies and devices for vaccine delivery

4. Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults

5. Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Facilitating the development of urgently required combination vaccines;The Lancet Global Health;2024-06

2. A worldwide overview for hexavalent vaccines and a glimpse into Turkiye’s perspective;Human Vaccines & Immunotherapeutics;2024-05-23

3. Experimental investigation of the optimal driving pressure for a larger-volume controllable jet injection system;Medical Engineering & Physics;2023-09

4. A Voice-Annotated Digital Decision Aid to Promote Child Influenza Vaccination: A Feasibility Study;Vaccines;2023-03-01

5. Challenges and opportunities in current vaccine technology and administration: A comprehensive survey examining oral vaccine potential in the United States;Human Vaccines & Immunotherapeutics;2022-09-09